Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Capital Reinvestment Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. capital reinvestment ratio. Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Capital Reinvestment Ratio of 0.09x as of September 2024, meaning it reinvests 0% of its operating cash flow (TL33.37 Million) in capital expenditures (TL2.91 Million). Check ONCSM cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2022–2022)
Capital reinvestment ratio of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2022 to 2022. This chart tracks Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s Capital Reinvestment Ratio across 1 annual periods. Also explore Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) net asset momentum to track the company's year-over-year net asset growth rate.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Capital Reinvestment Ratio by Year (2022–2022)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see ONCSM cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.49x | TL52.69 Million | TL26.02 Million | — |